Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Pharmacokinetics and bioavailability of midazolam in rats following single dose administration of intravenous solution, intranasal dispersion, and in situ nasal gel

Elahehnaz Parhizkar, Saba Movaffagh, Shohreh Alipour.




Abstract
Cited by 1 Articles

Midazolam (MDZ) is used as a sedative and anxiolytic agent in pediatric operations or dentistry procedures. Considering low solubility in physiologic pH, commercial intravenous MDZ formulation is constructed as an acidic solution, which is unofficially used orally, rectally, buccally, and intranasally in spite of low patient compliance due to irritation, inflammation, and caustic effect at administration sites. Due to the pathological safety of our previously designed MDZ poloxamer nasal gel (MDZ-PLX-GEL), its pharmacokinetic parameters were determined and compared to MDZ aqueous dispersion (MDZ-DIS) after intranasal administration in rats. MDZ-PLX-GEL was prepared using PLX (22% w/v), MDZ (1% w/v), and propylene glycol (10% v/v) in phosphate buffer pH 6. For better comparison, the commercial intravenous solution was evaluated as well. MDZ was analyzed using a validated high-performance liquid chromatography method. Male Sprague Dawley rats were used for in vivo experiments. The most important feature of MDZ-PLX-GEL was a rapid onset (20 minutes) with a mean residence time (MRT) of 170 minutes, which means MDZ effective blood concentration (100–200 ng/ml) lasts 3 hours which could increase MDZ-PLX-GEL absolute bioavailability up to 66.5%±4.6%. It was confirmed that the thermosensitive poloxamer gel was a suitable nasal carrier for MDZ that could increase its residence time, which may be a proper alternative for the currently unofficial routes of MDZ administration.

Key words: Midazolam, intranasal delivery, poloxamer gel, pharmacokinetics.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.